Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncotarget|July 14, 2020
Renal cell tumors convert natural killer cells to a proangiogenic phenotypeYue Guan, Christopher B Chambers, Taylor Tabatabai, et al.World Journal of Urology|May 9, 2021
Phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guérin treatmentShaheen Alanee, Sherjeel Sana, Ahmed El-Zawahry, et al.Sleep Health|November 13, 2022
The Emergency Medical Services Sleep Health Study: A cluster-randomized trialP Daniel Patterson, Sarah E Martin, Bridget N Brassil, et al.BMJ Open|January 14, 2025
Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancerUma Anne Mukherjee, Helen Hockings, Nicholas Counsell, et al.Clinical Genitourinary Cancer|March 30, 2024
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin TreatmentJazzmyne Montgomery, Daniel Lybbert, Sherjeel Sana, et al.Prehospital Emergency Care|November 19, 2016
Evidence-Based Guidelines for Fatigue Risk Management in EMS: Formulating Research Questions and Selecting OutcomesP Daniel Patterson, J Stephen Higgins, Eddy S Lang, et al.Pageof 3